News Release
Printer Friendly Version  View printer-friendly version << Back
Forward Pharma CFO to Present at Two Upcoming Conferences

COPENHAGEN, Denmark, Nov. 14, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis and other immune disorders such as psoriasis, today announced that Joel Sendek, Forward Pharma's Chief Financial Officer, will present at the following conferences:

  • The Stifel Nicolaus Healthcare Conference 2014 held at the Palace Hotel in New York, New York. Joel Sendek will present on Tuesday, November 18, 2014 at 4:10 PM EST.
  • The Jefferies 2014 Global Healthcare Conference held at the Waldorf Hilton Hotel in London, United Kingdom. Joel Sendek will present on Wednesday, November 19, 2014 at 5:00 PM GMT.

Investors and other interested parties may access a live audio webcast of the conference presentations by visiting Forward Pharma's website at

About Forward Pharma:  

Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a Phase 3 clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients. Since our founding in 2005, we have worked to advance unique formulations of DMF, an immune modulator, as a therapeutic to improve the health and well-being of patients with immune disorders including MS. FP187, our clinical candidate, is a DMF formulation in a delayed and slow release oral dose, which we plan to advance for the treatment of relapsing remitting MS, or RRMS, and other immune disorders, such as psoriasis.

Our principal executive offices are located at Østergade 24A, 1, 1100 Copenhagen K, Denmark and our American Depositary Shares are publicly traded on NASDAQ Stock Market (symbol: FWP). For more information about the Company's products and developments, please visit our web site at

Forward Pharma A/S Media Contacts:
Sharon Klahre, Director, Investor Relations
Forward Pharma USA, LLC
7 Skyline Drive
Hawthorne, NY 10532 

Andy Brimmer / Dan Katcher / Jennifer Beugelmans
Joele Frank, Wilkinson Brimmer Katcher

Forward Pharma